Cybin (HELP) Change in Receivables (2020 - 2026)
Cybin (HELP) posted quarterly Change in Receivables of -$262000.0 for Q1 2026, down 24.48% year-on-year from -$346946.4 in Q1 2025, and down 745.16% on a QoQ basis from -$31000.0 in Q4 2025.
Cybin (HELP) Change in Receivables (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Change in Receivables for 7 consecutive years, with -$262000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables fell 24.48% year-over-year to -$262000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$934000.0 (up 8.46% YoY) and the FY2026 annual result came in at -$934000.0, down 18.23% from the prior year.
- Change in Receivables declined to -$262000.0 in Q1 2026 per HELP's latest filing, from -$31000.0 in the prior quarter.
- Over the last five years, Change in Receivables for HELP reached as high as $380787.3 in Q2 2022 and fell as low as -$649485.3 in Q3 2024.
- A 5-year average of -$176312.9 and a median of -$163264.9 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables jumped 97.13% — and 2023, when it plunged 197.65%.
- Year by year, Change in Receivables stood at $178282.1 in 2022, then tumbled by 197.65% to -$174084.9 in 2023, then surged by 67.93% to -$55836.2 in 2024, then jumped by 44.48% to -$31000.0 in 2025, then slumped by 745.16% to -$262000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$262000.0, -$31000.0, and -$630000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | -262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -262,000.00 |
| Mar 31, 2026 | -262,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | -630,000.00 |
| Sep 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -210,468.78 |
| Mar 31, 2025 | -210,468.78 |
| Dec 31, 2024 | -55,836.23 |
| Dec 31, 2024 | -55,836.23 |
| Sep 30, 2024 | -649,485.32 |
| Sep 30, 2024 | -649,485.32 |
| Jun 30, 2024 | -104,553.10 |
| Jun 30, 2024 | -104,553.10 |
| Mar 31, 2024 | -163,264.91 |
| Mar 31, 2024 | -163,264.91 |
| Dec 31, 2023 | -174,084.92 |
| Dec 31, 2023 | -174,084.92 |